Omega Therapeutics, Inc. (OMGA)

NASDAQ: OMGA · IEX Real-Time Price · USD

2.340

-0.050 (-2.09%)

At close: Apr 23, 2024, 4:00 PM

2.390

+0.050 (2.14%)

Pre-market: Apr 24, 2024, 7:01 AM EDT

Omega Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	129	166	274	541	-	-
Market Cap Growth	-	-39.50%	-49.31%	-	-	-
Enterprise Value	184	221	172	335	-12	9
PE Ratio	-1.70	-1.70	-2.67	-7.93	-	-
PS Ratio	41.71	53.65	132.35	3758.96	-	-
PB Ratio	2.22	2.86	2.59	2.70	-	-
P/FCF Ratio	-1.77	-1.77	-2.75	-9.16	-	-
P/OCF Ratio	-1.81	-1.81	-2.78	-9.40	-	-
EV/Sales Ratio	59.38	71.31	82.93	2329.80	-	-
EV/EBITDA Ratio	-2.43	-2.43	-1.76	-5.08	0.42	-0.56
EV/EBIT Ratio	-2.26	-2.26	-1.67	-4.98	0.40	-0.53
EV/FCF Ratio	-2.35	-2.35	-1.72	-5.68	0.41	-0.56
Debt / Equity Ratio	2.21	2.21	0.21	0.10	-0.18	-0.33
Debt / EBITDA Ratio	-1.42	-1.42	-0.23	-0.30	-0.43	-0.72
Debt / FCF Ratio	-1.37	-1.37	-0.23	-0.34	-0.42	-0.72
Quick Ratio	2.98	2.98	5.72	18.85	3.03	1.17
Current Ratio	3.35	3.35	6.26	19.13	3.12	1.19
Asset Turnover	0.02	0.02	0.01	0.00	0	-
Interest Coverage	-	-	-	-74.03	-36.90	-29.16
Return on Equity (ROE)	-110.40%	-110.40%	-71.00%	-109.00%	58.60%	-
Return on Assets (ROA)	-48.30%	-48.30%	-56.60%	-36.40%	-172.20%	-
Return on Capital (ROIC)	-53.78%	-53.78%	-79.94%	-29.95%	54.21%	72.12%
Earnings Yield	-75.49%	-58.70%	-37.43%	-12.61%	-	-
FCF Yield	-72.62%	-56.47%	-36.41%	-10.91%	-	-
Buyback Yield / Dilution	-12.80%	-12.80%	-113.71%	-473.56%	68.85%	-
Total Shareholder Return	-12.80%	-12.80%	-113.71%	-473.56%	68.85%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).